mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Cancer Discovery|2017Cited by 110
MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in <i>BRAF-, NRAS</i> -, and <i>NF1</i> -Mutant MelanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Cancer Discovery|2019Cited by 106
Abstract LB-113: MAPK pathway suppression unmasks latent DNA repair defects and confers a chemical synthetic vulnerability in<i>BRAF</i>,<i>NRAS</i>and<i>NF1-</i>mutant melanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Experimental and Molecular Therapeutics|2019Cited by 0
Abstract LB-113: MAPK pathway suppression unmasks latent DNA repair defects and confers a chemical synthetic vulnerability in <i>BRAF</i> , <i>NRAS</i> and <i>NF1-</i> mutant melanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Cancer Research|2019Cited by 0
Supplemental Figures and Table from mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Unknown|2023Cited by 0